Skip to content
healthcare.dev

Zanaflex

NDC 83107-004, tizanidine hydrochloride, tablet, from Legacy Pharma USA, Inc..

Product NDC
83107-004
Status
Listed
Labeler
Legacy Pharma USA, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA020397
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83107-004 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TIZANIDINE HYDROCHLORIDE4 mg/1

Pharmacologic classes

Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
83107-004-1583107000415150 TABLET in 1 BOTTLE (83107-004-15)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/60c27d35-7349-4fc6-86ad-70fffdbe3e08

Use it

Look up 83107-004 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83107-004 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83107-004. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.